HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysis.

Anders Wilder Erickson Farinaz Ghodrati Steven Habbous Katarzyna J Jerzak Arjun Sahgal Manmeet S Ahluwalia Sunit Das

Published in: Neuro-oncology advances (2020)

These findings support a potential role for systemic HER2-targeted therapy in the treatment of patients with IMD from HER2-positive metastatic breast cancer.

Keyphrases

positive breast cancer
metastatic breast cancer
squamous cell carcinoma
small cell lung cancer
combination therapy
free survival